HCA HCA Healthcare, Inc. Common Stock

NYSE · Health Care · SEC EDGAR에서 보기 ↗
$420.53
가격 · 8월 19, 2026
기준 재무 정보 7월 28, 2026

HCA Healthcare, Inc. Common Stock 정보 위키백과 회사 개요

HCA Healthcare, Inc. is an American global for-profit operator of health care facilities that was founded in 1968. It is based in Nashville, Tennessee, and, as of May 2020, owned and operated 186 hospitals and approximately 2,400 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics in 20 states and the United Kingdom. As of 2024, HCA Healthcare is ranked #61 on the Fortune 500 rankings of the largest United States corporations by total revenue. In the 1990s, the company engaged in illegal accounting and other crimes that resulted in the payment of more than $2 billion in federal fines and other penalties, and the dismissal of the CEO Rick Scott by the board of directors.

더 보기

HCA Healthcare, Inc. (historically known as Hospital Corporation of America) is an American global for-profit operator of health care facilities that was founded in 1968. It is based in Nashville, Tennessee, and, as of May 2020, owned and operated 186 hospitals and approximately 2,400 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics in 20 states and the United Kingdom. As of 2024, HCA Healthcare is ranked #61 on the Fortune 500 rankings of the largest United States corporations by total revenue. In the 1990s, the company engaged in illegal accounting and other crimes that resulted in the payment of more than $2 billion in federal fines and other penalties, and the dismissal of the CEO Rick Scott by the board of directors.

History

Early years

The Hospital Corporation of America (HCA) was founded in 1968 in Nashville, Tennessee, by Thomas F. Frist Sr., Thomas F. Frist Jr. and Jack C. Massey. The founders envisioned a company that would bring together hospitals to deliver patient-focused care while using the combined resources of the organization to strengthen hospitals and improve the practice of medicine. The company began with Nashville's Park View Hospital, which the elder Frist had founded in 1960 with other doctors and where he was serving as chief executive.

The company included 11 hospitals when it filed its initial public offering on the New York Stock Exchange (NYSE) in 1969 and had 26 hospitals and 3,000 beds by the end of the year.

Growth and merger

The 1970s were characterized by rapid growth in the industry and for HCA Healthcare. In the early 1980s, the focus shifted to consolidation with HCA Healthcare acquiring General Care Corporation, General Health Services, Hospital Affiliates International and Health Care Corporation. By the end of 1981, the company operated 349 hospitals with more than 49,000 beds. Operating revenues had grown to $2.4 billion.

In 1987, HCA Healthcare, which had grown to operate 463 hospitals (255 owned and 208 managed), spun off HealthTrust, a privately owned, 104-hospital company. Believing its stock was undervalued, the company completed a $5.1 billion leveraged management buyout led by chairman Thomas F. Frist Jr. in 1988. HCA Healthcare re-emerged as a public company in 1992.

In February 1994, HCA Healthcare merged with Louisville, Kentucky-based Columbia Hospital Corporation, which earlier had acquired 73 hospitals of Galen Health Care from Humana,

to form Columbia/HCA Healthcare Corporation. Related names of note include HCA International and Health Corporation of America.

Columbia Hospital Corporation

In 1988, Rick Scott and Richard Rainwater each put up $125,000 in working capital in their new company, Columbia Hospital Corporation; they borrowed the remaining money needed to purchase two struggling hospitals in El Paso for $60 million. Then they acquired a neighboring hospital and shut it down. Within a year, the remaining two were doing much better. By the end of 1989, Columbia Hospital Corporation owned four hospitals with a total of 833 beds.

In 1992, Columbia made a stock purchase of Basic American Medical, which owned eight hospitals, primarily in southwestern Florida. In September 1993, Columbia did another stock purchase, worth $3.4 billion, of Galen Healthcare, which had been spun off by Humana Inc. several months earlier. At the time, Galen had approximately 90 hospitals. After the purchase, Galen stockholders had 82% of the stock in the combined company, with Scott still running the company.

Recent history

On November 17, 2006, HCA became a private company for the third time when it completed a merger in which the company was acquired by a private investor group including affiliates of Kohlberg Kravis Roberts and Bain Capital, together with Merrill Lynch and HCA Healthcare founder Thomas F. Frist Jr. The total transaction was valued at approximately $33 billion, making it the largest leveraged buyout in history at the time, eclipsing the 1989 buyout of RJR Nabisco.

In May 2010, HCA announced that the corporation would once again go public with an expected $4.6-billion IPO as HCA Holdings, Inc. In March 2011, HCA sold 126.2 million shares for $30 each, raising about $3.79 billion, at that time, the largest private-equity backed IPO in U.S. history. In May 2017, the corporation was renamed HCA Healthcare.

In December 2018, a historical marker was installed in the parking lot of HCA's Sarah Cannon Cancer Center in Nashville, formerly the location of HCA's first hospital, Park View Hospital.

In 2018, the company was ranked No. 67 in the 2019 Fortune 500 list of the largest United States corporations by total revenue.

In May 2021, the company finalized a deal with Google to develop healthcare algorithms using patient records. In August 2021, HCA announced a deal with venture capital firm General Catalyst to develop digital solutions to streamline workflows and improve patient care; as part of the deal, HCA sold its healthcare app development firm PatientKeeper to General Catalyst's portfolio company Commure.

In April 2022, HCA Healthcare announced a $1.5 million partnership with Florida International University's Nicole Wertheim college of Nursing and Health Sciences, to expand its facilities to address the national nursing shortage.

In October 2022, LCMC Health in partnership with Tulane University announced that it would acquire Tulane Medical Center, Lakeview Regional Medical Center, and Tulane Lakeside Hospital from HCA for $150 million pending regulatory approval.

In March 2024, it was announced HCA had completed the sale of West Hills Hospital and Medical Center and related assets in Los Angeles, California to UCLA Health, for an undisclosed amount.

Facilities

United States

As of 2024, HCA has 186 hospitals. They also report operating more than 2,400 additional sites of care, including surgery centers, freestanding ERs, urgent care centers, and physician clinics located in 20 U.S. states and in the United Kingdom. A significant portion of those hospitals are situated in Florida and Texas. As of 2022, HCA had 47 hospitals and 31 surgery centers in Florida, and 45 hospitals and 632 affiliated sites of care in Texas. In 2021, it announced plans to build 3 new hospitals in Florida. In 2022, The Dallas Morning News reported that HCA will build 5 new hospitals in Texas. They also have a strong presence in Tennessee, where it began. HCA had 13 hospitals there as of 2019.

Between 2003 and 2017, HCA did not enter any new markets. However, in July 2007, HCA sold its hospitals in Switzerland.

In 2017, HCA acquired the Memorial University Medical Center in Savannah, Georgia. That same year, they acquired three Houston, Texas, hospitals from Tenet Healthcare.

In 2019 they purchased Mission Health System which operates hospitals in North Carolina.

In January 2020, HCA Healthcare acquired Valify, a healthcare cost-management company. In May 2020, HCA acquired 49-bed Shands Starke (Fla.) Regional Medical Center and 25-bed Shands Live Oak (Fla.) Regional Medical Center from CHS. HCA is operating the two facilities as off-campus emergency departments of Lake City (Fla.) Medical Center and North Florida Regional Medical Center in Gainesville. Later that year, it signed an agreement to sell Garden Park Medical Center to Singing River Health System.

In 2021, HCA sold Redmond Regional Medical Center to AdventHealth for $635M, and four other Georgia hospitals to Piedmont Healthcare for $950 million. They also announced the acquisition of Meadows Regional Medical Center.

United Kingdom

HCA International, the UK arm of Hospital Corporation of America, "caters for around half of all private patients in London." The main hospital sites within the United Kingdom it operates include:

It opened urgent care walk-in centres at London Bridge Hospital and the Portland Hospital in March 2018. It claims that patients, on average, wait just seven minutes to see a nurse and 17 minutes to see a doctor. In February 2022, outsourced cleaning staff at London Bridge Hospital reported a lack of PPE, no access to sick pay, a lack of training and no prior warning about which rooms may be contaminated with the virus through the COVID-19 pandemic.

The Princess Grace Hospital specializes in breast cancer and surgery, aided by Kefah Mokbel and Nick Perry who, in 2005, founded The London Breast Institute.

The company opened The Harborne Hospital, a newly built private hospital located close to the Queen Elizabeth Hospital, Birmingham, in February 2024.

Significant areas of operation

Medical education

In recent years, HCA Healthcare has become a significant provider of clinical and medical education. It is the largest sponsor of graduate medical education programs in the U.S., with 56 teaching hospitals in 14 states, primarily in regions with a deficit of physician training programs. The company includes Research College of Nursing and Mercy School of Nursing, and has several advanced nursing simulation training centers. In early 2020, it completed the purchase of a majority stake in Galen College of Nursing, which operates 21 campuses in 12 states, offering Bachelor of Science and Associate of Science nursing degrees.

Controversies

Medicare billing practices lawsuit

In 1993, lawsuits were filed against HCA by former employees who alleged that the company had engaged in questionable Medicare billing practices. In 1997, with a federal investigation by the FBI, the IRS and the Department of Health and Human Services in its early stages, the Columbia/HCA board of directors forced Rick Scott to resign as chairman and CEO amid growing evidence that the company "had kept two sets of books, one to show the government and one with actual expenses listed." Thomas Frist, a co-founder of HCA and brother of U.S. Senator Bill Frist, returned to the company as CEO in 1997 and called on longtime friend and colleague Jack O. Bovender Jr. to help him turn the company around.

The federal probe culminated in 2003 with "the government receiving a total of over $2 billion in criminal fines and civil penalties for systematically defrauding federal health care programs." Columbia/HCA pleaded guilty to 14 felonies and admitted to systematically overcharging the government. The federal probe has been referred to as the longest and costliest investigation for health-care fraud in U.S. history.

2005 insider trading suit

In July 2005, U.S. Senator Bill Frist sold all of his HCA shares, which were held in a blind trust, two weeks before disappointing earnings sent the stock on a 9-point plunge. At the time, Frist was considering a run for president and said that he had sold his shares to avoid the appearance of a conflict of interest. When the company disclosed that other executives had also sold their shares during that same time, shareholders alleged that the company had made false claims about its profits to drive up the price, which then fell when the company reported disappointing financial results. Eleven of HCA's senior officers were sued for accounting fraud and insider trading. HCA settled the lawsuit in August 2007, agreeing to pay $20 million to the shareholders but admitting no wrongdoing, and no charges were brought.

COVID-19 PPE

During the COVID-19 pandemic in the United States, HCA hospital nurses and other workers spoke out about the lack of PPE. In April 2020, there was an outcry against HCA following the deaths of two nurses Celia Yap-Banago and Rosa Luna who worked at HCA hospitals in Kansas City and California and had contracted coronavirus, despite the alarm having been raised about the lack of PPE at work.

Mission Hospital Acquisition Complaints

On December 14, 2023, the North Carolina Attorney General sued HCA for violating the terms of an agreement that allowed HCA to purchase Mission Health.

On February 13, 2024, HCA Healthcare denied the allegations and asked a judge to dismiss the lawsuit by the Attorney General, and in return the hospital network filed a counterclaim against the Attorney General.

출처: 위키백과 (영어), CC BY-SA 4.0 · 위키백과에서 보기 ↗

Wikidata ↗

HCA 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위

가격
$420.53
시가총액
$94.45B
P/E (TTM)
14.8
EPS (TTM)
$28.33
매출 (TTM)
$75.60B
배당 수익률
0.72%
ROE
-159.1%
부채/자본
-6.9
52주 범위
$354 – $557

HCA 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의

10년 성과 매출, 순이익, 마진 및 EPS 추세

매출 및 순이익 $75.60B
10-point trend, +82.2%
2016-12-31 2025-12-31
EPS $28.33
10-point trend, +288.1%
2016-12-31 2025-12-31
잉여현금흐름 $7.69B
10-point trend, +165.9%
2016-12-31 2025-12-31
마진 9.0%

가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?

지표
5년 추세
HCA
동종업계 중앙값
P/E (TTM)
5-point trend, +35.7%
14.8
20.3
P/S (TTM)
5-point trend, +3.8%
1.2
1.1
P/B
5-point trend, +79.3%
-15.7
4.5
EV / EBITDA
5-point trend, +5.5%
38.3
Price / FCF (주가 / FCF)
5-point trend, -6.5%
12.3

수익성 총, 영업 및 순이익률; ROE, ROA, ROIC

지표
5년 추세
HCA
동종업계 중앙값
Net Profit Margin (순이익률)
5-point trend, -24.2%
9.0%
7.4%
ROA
5-point trend, -20.3%
11.3%
6.6%
ROE
5-point trend, +95.9%
-159.1%
23.2%

재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성

지표
5년 추세
HCA
동종업계 중앙값
Debt / Equity (부채 / 자기자본 비율)
5-point trend, +81.4%
-6.9
Current Ratio (유동비율)
5-point trend, -31.7%
1.0
1.2
Quick Ratio (당좌 비율)
5-point trend, -26.9%
0.7

성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR

지표
5년 추세
HCA
동종업계 중앙값
Revenue YoY (매출 YoY)
5-point trend, +28.7%
7.1%
Revenue CAGR 3Y (매출 CAGR 3년)
5-point trend, +28.7%
7.9%
Revenue CAGR 5Y (매출 CAGR 5년)
5-point trend, +28.7%
8.0%
EPS YoY
5-point trend, +33.9%
28.8%
Net Income YoY (순이익 YoY)
5-point trend, -2.5%
17.8%

주당 지표 EPS, 주당 순자산, 주당 현금 흐름, 주당 배당금

지표
5년 추세
HCA
동종업계 중앙값
EPS (Diluted) (EPS (희석))
5-point trend, +33.9%
$28.33

자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율

지표
5년 추세
HCA
동종업계 중앙값
Payout Ratio (지급 비율)
5-point trend, +11.6%
10.0%

배당금 배당 수익률, 지급 비율, 배당 이력, 5년 CAGR

배당 수익률
0.72%
지급 비율
10.0%
5년 배당 CAGR
배당락일금액
2026년 6월 16일$0.7800
2026년 3월 17일$0.7800
2025년 12월 15일$0.7200
2025년 9월 16일$0.7200
2025년 6월 16일$0.7200
2025년 3월 17일$0.7200
2024년 12월 13일$0.6600
2024년 9월 16일$0.6600
2024년 6월 14일$0.6600
2024년 3월 14일$0.6600
2023년 12월 13일$0.6000
2023년 9월 14일$0.6000
2023년 6월 15일$0.6000
2023년 3월 16일$0.6000
2022년 12월 13일$0.5600
2022년 9월 15일$0.5600
2022년 6월 15일$0.5600
2022년 3월 16일$0.5600
2021년 12월 13일$0.4800
2021년 9월 15일$0.4800

HCA 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력

매수 30 명의 애널리스트
  • 적극 매수 6 20.0%
  • 매수 11 36.7%
  • 보유 12 40.0%
  • 매도 1 3.3%
  • 적극 매도 0 0.0%

12개월 목표 주가

21 명의 애널리스트 · 2026-08-17
중앙값 목표 $450.00 +7.0%
평균 목표 $454.57 +8.1%

실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일

평균 서프라이즈
0.49%
기간 EPS Actual EPS 예상 서프라이즈
2026년 6월 30일 $7.62 $7.54 0.08%
2026년 3월 31일 $7.15 $7.21 -0.06%
2025년 12월 31일 $8.14 $7.53 0.61%
2025년 9월 30일 $6.96 $5.77 1.2%
2025년 6월 30일 $6.83 $6.31 0.52%
2025년 3월 31일 $6.45 $5.84 0.61%

동종 기업 비교(GICS 하위 산업) 주요 지표 대 섹터 동종 기업

티커 시가총액 P/E 매출 YoY 순이익률 ROE 매출 총이익률
HCA $104.86B 16.5 7.1% 9.0% -159.1%
THC $17.28B 12.8 3.1% 11.1% 56.4%
EHC $10.61B 19.2 10.5% 9.5% 25.1%
ENSG $10.12B 29.8 18.7% 6.8% 16.9%
UHS 9.4 9.7% 8.6% 21.4%
PACS $6.01B 31.5 29.3% 3.6% 23.1%
CON $2.53B 15.1 13.9% 7.7% 49.8%
BKD $2.57B -9.6 2.2% -8.2% -313.2% 26.2%
ACHC $1.28B -1.2 5.0% -33.3% -43.9%
SNDA $612M -7.7 25.2% -18.6% -197.2%

전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름

손익계산서 12
HCA의 연간 손익계산서 데이터
지표 추세 2025202420232022202120202019201820172016
Revenue 10-point trend, +82.2% $75.60B $70.60B $64.97B $60.23B $58.75B $51.53B $51.34B $46.68B $43.61B $41.49B
SG&A Expense 10-point trend, +59.8% $548M $421M $353M $307M $337M $416M $370M $344M $340M $343M
Operating Expenses 10-point trend, +79.3% $65.77B $62.08B $57.26B $51.65B $48.92B $46.10B $46.09B $41.34B $39.23B $36.68B
Interest Expense 10-point trend, +31.7% $2.25B $2.06B $1.94B $1.74B $1.57B $1.58B $1.82B $1.75B $1.69B $1.71B
Pretax Income 10-point trend, +104.4% $9.83B $8.52B $7.71B $8.58B $9.83B $5.43B $5.24B $5.33B $4.38B $4.81B
Income Tax 10-point trend, +48.8% $2.05B $1.87B $1.61B $1.75B $2.11B $1.04B $1.10B $946M $1.64B $1.38B
Net Income 10-point trend, +134.7% $6.78B $5.76B $5.24B $5.64B $6.96B $3.75B $3.50B $3.79B $2.22B $2.89B
EPS (Basic) 10-point trend, +281.1% $28.70 $22.27 $19.25 $19.43 $21.52 $11.10 $10.27 $10.90 $6.12 $7.53
EPS (Diluted) 10-point trend, +288.1% $28.33 $22.00 $18.97 $19.15 $21.16 $10.93 $10.07 $10.66 $5.95 $7.30
Shares (Basic) 10-point trend, -38.4% 236,413,000 258,603,000 272,404,000 290,348,000 323,315,000 338,274,000 341,210,000 347,297,000 362,305,000 383,591,000
Shares (Diluted) 10-point trend, -39.5% 239,495,000 261,806,000 276,412,000 294,666,000 328,752,000 343,605,000 348,226,000 355,303,000 372,221,000 395,851,000
EBITDA 10-point trend, +79.2% $3.52B $3.31B $3.08B $2.97B $2.85B $2.72B $2.60B $2.28B $2.13B $1.97B
대차대조표 22
HCA의 연간 대차대조표 데이터
지표 추세 2025202420232022202120202019201820172016
Cash & Equivalents 10-point trend, +61.0% $1.04B $1.93B $935M $908M $1.45B $1.79B $621M $502M $732M $646M
Short-term Investments 5-point trend, +136.7% · · · · · $116M $147M $47M $54M $49M
Receivables 10-point trend, +86.5% $10.87B $10.75B $9.96B $8.89B $8.10B $7.05B $7.38B $6.79B $6.50B $5.83B
Inventory 10-point trend, +9.9% $1.65B $1.74B $2.02B $2.07B $1.99B $2.02B $1.85B $1.73B $1.57B $1.50B
Other Current Assets 10-point trend, +100.2% $2.22B $1.99B $2.01B $1.78B $2.01B $1.46B $1.35B $1.19B $1.17B $1.11B
Current Assets 10-point trend, +73.7% $15.78B $16.41B $14.93B $13.64B $13.54B $12.33B $11.20B $10.21B $9.98B $9.09B
PP&E (Net) 10-point trend, +90.4% $31.14B $29.41B $27.71B $25.57B $24.06B $23.20B $22.71B $19.76B $17.89B $16.35B
PP&E (Gross) 10-point trend, +78.9% $66.28B $62.51B $58.55B $54.76B $51.35B $49.32B $47.23B $42.97B $40.08B $37.05B
Accum. Depreciation 10-point trend, +69.7% $35.13B $33.10B $30.83B $29.18B $27.29B $26.12B $24.52B $23.21B $22.19B $20.70B
Other Non-current Assets 10-point trend, -76.3% $255M $230M $184M $298M $598M $546M $480M $690M $710M $1.07B
Total Assets 10-point trend, +79.9% $60.72B $59.51B $56.21B $52.44B $50.74B $47.49B $45.06B $39.21B $36.59B $33.76B
Accounts Payable 10-point trend, +101.0% $4.66B $4.28B $4.23B $4.24B $4.11B $3.54B $2.90B $2.58B $2.61B $2.32B
Current Liabilities 10-point trend, +180.3% $16.35B $15.18B $12.65B $9.90B $9.58B $8.70B $7.76B $7.57B $6.16B $5.83B
Capital Leases 7-point trend, +23.6% $1.85B $1.86B $1.90B $1.75B $1.75B $1.67B $1.50B · · ·
Total Liabilities 4-point trend, +15.8% · · · · · · $45.62B $42.12B $41.59B $39.39B
Long-term Debt 10-point trend, +41.1% $44.28B $43.03B $39.59B $38.08B $34.58B $31.00B $33.72B $32.82B $33.06B $31.38B
Total Debt 10-point trend, +32.6% $41.60B $43.03B $39.59B $38.08B $34.58B $31.00B $33.72B $32.82B $33.06B $31.38B
Retained Earnings 10-point trend, +17.9% $-5.72B $-2.12B $-1.35B $-2.28B $-532M $777M $-2.35B $-4.57B $-6.53B $-6.97B
AOCI 10-point trend, +9.8% $-305M $-387M $-425M $-490M $-404M $-502M $-460M $-381M $-278M $-338M
Stockholders' Equity 10-point trend, +17.5% $-6.03B $-2.50B $-1.77B $-2.77B $-933M $572M $-2.81B $-4.95B $-6.81B $-7.30B
Liabilities + Equity 10-point trend, +79.9% $60.72B $59.51B $56.21B $52.44B $50.74B $47.49B $45.06B $39.21B $36.59B $33.76B
Shares Outstanding 10-point trend, -39.4% 224,605,100 249,981,400 265,537,300 277,378,300 305,476,800 339,425,600 338,445,600 342,895,200 350,091,600 370,535,900
현금 흐름 17
HCA의 연간 현금 흐름 데이터
지표 추세 2025202420232022202120202019201820172016
D&A 10-point trend, +79.2% $3.52B $3.31B $3.08B $2.97B $2.85B $2.72B $2.60B $2.28B $2.13B $1.97B
Stock-based Comp 10-point trend, +59.8% $401M $360M $262M $341M $440M $362M $347M $268M $270M $251M
Amort. of Intangibles 6-point trend, -53.8% $12M $16M $20M $44M $25M $26M · · · ·
Other Non-cash 10-point trend, +172.2% $1.93B $1.08B $850M $-431M $-1.29B $2.40B $1.07B $461M $-3.53B $-2.67B
Operating Cash Flow 10-point trend, +123.5% $12.64B $10.51B $9.43B $8.52B $8.96B $9.23B $7.60B $6.76B $5.43B $5.65B
CapEx 10-point trend, +79.1% $4.94B $4.88B $4.74B $4.39B $3.58B $2.83B $4.16B $3.57B $3.02B $2.76B
Investing Cash Flow 10-point trend, -54.0% $-4.99B $-4.93B $-5.32B $-3.39B $-2.64B $-3.39B $-5.72B $-3.90B $-4.28B $-3.24B
Debt Issued 10-point trend, +56.9% $8.47B $7.50B $3.22B $6.00B $4.34B $2.70B $6.45B $2.00B $1.50B $5.40B
Net Debt Issued 10-point trend, +17.3% $1.08B $5.08B $2.31B $3.17B $475M $-737M $1.13B $296M $749M $925M
Stock Repurchased 10-point trend, +265.9% $10.07B $6.04B $3.81B $7.00B $8.21B $441M $1.03B $1.53B $2.05B $2.75B
Net Stock Activity 10-point trend, -265.9% $-10.07B $-6.04B $-3.81B $-7.00B $-8.21B $-441M $-1.03B $-1.53B $-2.05B $-2.75B
Dividends Paid 9-point trend, +679000000.00 $679M $690M $661M $653M $624M $153M $550M $487M $0 ·
Financing Cash Flow 10-point trend, -240.9% $-8.55B $-4.58B $-4.09B $-5.66B $-6.66B $-4.68B $-1.77B $-3.08B $-1.06B $-2.51B
Net Change in Cash 10-point trend, -840.0% $-893M $998M $27M $-543M $-342M $1.17B $119M $-230M $86M $-95M
Taxes Paid 10-point trend, +38.6% $1.74B $1.84B $1.39B $1.18B $2.18B $1.00B $849M $872M $1.21B $1.25B
Free Cash Flow 10-point trend, +165.9% $7.69B $5.64B $4.69B $4.13B $5.38B $6.40B $3.44B $3.19B $2.41B $2.89B
Levered FCF 10-point trend, +253.0% $5.91B $4.03B $3.16B $2.74B $4.15B $5.12B $2.00B $1.74B $1.35B $1.68B
수익성 5
HCA의 연간 수익성 데이터
지표 추세 2025202420232022202120202019201820172016
Net Margin 8-point trend, +10.6% 9.0% 8.2% 8.1% 9.4% 11.8% 7.3% 6.8% 8.1% · ·
Pretax Margin 8-point trend, +13.8% 13.0% 12.1% 11.9% 14.2% 16.7% 10.5% 10.2% 11.4% · ·
EBITDA Margin 8-point trend, -4.5% 4.7% 4.7% 4.7% 4.9% 4.9% 5.3% 5.1% 4.9% · ·
ROA 10-point trend, +29.8% 11.3% 10.0% 9.7% 10.9% 14.2% 8.1% 8.3% 10.0% 6.3% 8.7%
ROE 10-point trend, -310.3% -159.1% -269.6% -230.9% -305.0% -3853.7% -335.8% -90.4% -64.4% -31.4% -38.8%
유동성 및 지급능력 4
HCA의 연간 유동성 및 지급능력 데이터
지표 추세 2025202420232022202120202019201820172016
Current Ratio 10-point trend, -38.0% 1.0 1.1 1.2 1.4 1.4 1.4 1.4 1.3 1.6 1.6
Quick Ratio 10-point trend, -34.8% 0.7 0.8 0.9 1.0 1.0 1.0 1.1 1.0 1.2 1.1
Debt / Equity 10-point trend, -60.6% -6.9 -17.2 -22.3 -13.8 -37.1 54.2 -12.0 -6.6 -4.9 -4.3
LT Debt / Equity 10-point trend, -61.8% -6.9 -15.3 -21.0 -13.6 -36.8 53.8 -12.0 -6.5 -4.8 -4.3
효율성 2
HCA의 연간 효율성 데이터
지표 추세 2025202420232022202120202019201820172016
Asset Turnover 8-point trend, +2.1% 1.3 1.2 1.2 1.2 1.2 1.1 1.2 1.2 · ·
Receivables Turnover 8-point trend, -0.4% 7.0 6.8 6.9 7.1 7.8 7.1 7.2 7.0 · ·
주당 6
HCA의 연간 주당 데이터
지표 추세 2025202420232022202120202019201820172016
Book Value / Share 10-point trend, -36.2% $-26.83 $-10.00 $-6.68 $-9.98 $-3.05 $1.69 $-8.30 $-14.44 $-19.44 $-19.71
Revenue / Share 8-point trend, +140.3% $315.66 $269.68 $235.04 $204.41 $178.71 $149.98 $147.42 $131.37 · ·
Cash Flow / Share 10-point trend, +269.5% $52.76 $40.16 $34.12 $28.92 $27.25 $26.87 $21.83 $19.03 $14.58 $14.28
Cash / Share 10-point trend, +165.6% $4.63 $7.73 $3.52 $3.27 $4.75 $5.28 $1.83 $1.46 $2.09 $1.74
Dividend / Share 8-point trend, +105.7% $3 $3 $2 $2 $2 $0 $2 $1 · ·
EPS (TTM) 10-point trend, +288.1% $28.33 $22.00 $18.97 $19.15 $21.16 $10.93 $10.07 $10.66 $5.95 $7.30
성장률 10
HCA의 연간 성장률 데이터
지표 추세 2025202420232022202120202019201820172016
Revenue YoY 5-point trend, -49.5% 7.1% 8.7% 7.9% 2.5% 14.0% · · · · ·
Revenue CAGR 3Y 3-point trend, -2.0% 7.9% 6.3% 8.0% · · · · · · ·
Revenue CAGR 5Y 8.0% · · · · · · · · ·
EPS YoY 5-point trend, -69.3% 28.8% 16.0% -0.94% -9.5% 93.6% · · · · ·
EPS CAGR 3Y 3-point trend, -30.9% 13.9% 1.3% 20.2% · · · · · · ·
EPS CAGR 5Y 21.0% · · · · · · · · ·
Net Income YoY 5-point trend, -79.2% 17.8% 9.9% -7.1% -18.9% 85.3% · · · · ·
Net Income CAGR 3Y 3-point trend, -46.2% 6.3% -6.1% 11.8% · · · · · · ·
Net Income CAGR 5Y 12.6% · · · · · · · · ·
Dividend CAGR 5Y 34.7% · · · · · · · · ·
가치 평가 (TTM) 17
HCA의 연간 가치 평가 (TTM) 데이터
지표 추세 2025202420232022202120202019201820172016
Revenue TTM 10-point trend, +82.2% $75.60B $70.60B $64.97B $60.23B $58.75B $51.53B $51.34B $46.68B $43.61B $41.49B
Net Income TTM 10-point trend, +134.7% $6.78B $5.76B $5.24B $5.64B $6.96B $3.75B $3.50B $3.79B $2.22B $2.89B
Market Cap 10-point trend, +282.3% $104.86B $75.03B $71.88B $66.56B $78.48B $55.82B $50.03B $42.67B $30.75B $27.43B
Enterprise Value 10-point trend, +150.3% $145.42B $116.13B $110.53B $103.74B $111.61B $84.92B $82.98B $74.95B $63.02B $58.11B
P/E 10-point trend, +62.5% 16.5 13.6 14.3 12.5 12.1 15.0 14.7 11.7 14.8 10.1
P/S 10-point trend, +109.8% 1.4 1.1 1.1 1.1 1.3 1.1 1.0 0.9 0.7 0.7
P/B 10-point trend, -363.2% -17.4 -30.0 -40.5 -24.1 -84.1 97.6 -17.8 -8.6 -4.5 -3.8
P / Tangible Book · · · · · 97.6 · · · ·
P / Cash Flow 10-point trend, +71.0% 8.3 7.1 7.6 7.8 8.8 6.0 6.6 6.3 5.7 4.9
P / FCF 10-point trend, +43.8% 13.6 13.3 15.3 16.1 14.6 8.7 14.5 13.4 12.8 9.5
EV / EBITDA 10-point trend, +39.7% 41.3 35.1 35.9 34.9 39.1 31.2 32.0 32.9 29.6 29.6
EV / FCF 10-point trend, -5.9% 18.9 20.6 23.6 25.1 20.7 13.3 24.1 23.5 26.1 20.1
EV / Revenue 10-point trend, +37.4% 1.9 1.6 1.7 1.7 1.9 1.6 1.6 1.6 1.4 1.4
Dividend Yield 9-point trend, +0.01 0.65% 0.92% 0.92% 0.98% 0.80% 0.27% 1.1% 1.1% 0.00% ·
Earnings Yield 10-point trend, -38.4% 6.1% 7.3% 7.0% 8.0% 8.2% 6.7% 6.8% 8.6% 6.8% 9.9%
Payout Ratio 8-point trend, -22.2% 10.0% 12.0% 12.6% 11.6% 9.0% 4.1% 15.7% 12.9% · ·
Annual Payout 9-point trend, +679000000.00 $679M $690M $661M $653M $624M $153M $550M $487M $0 ·

재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년

손익계산서
2025-12-312024-12-312023-12-312022-12-312021-12-31
매출 $75.60B$70.60B$64.97B$60.23B$58.75B
순이익 $6.78B$5.76B$5.24B$5.64B$6.96B
희석 EPS $28.33$22.00$18.97$19.15$21.16
대차대조표
2025-12-312024-12-312023-12-312022-12-312021-12-31
부채 / 자기자본 비율 -6.9-17.2-22.3-13.8-37.1
유동비율 1.01.11.21.41.4
당좌 비율 0.70.80.91.01.0
현금 흐름
2025-12-312024-12-312023-12-312022-12-312021-12-31
잉여현금흐름 $7.69B$5.64B$4.69B$4.13B$5.38B

최신 뉴스 이 회사 관련 최근 헤드라인

나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목

📊

중요한 지표를 선택하세요 — 위 전체 기본 재무제표의 아무 행 옆에 있는 ➕를 클릭하세요.

선택 항목이 저장되어 모든 티커에서 유지됩니다.

기관 투자자 (13F) 1,491개의 제출자 · $39.4B 전체 · 기준일 2026년 6월 30일

분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.

기관 활동 — Q2 2026 대 이전 분기
신규 포지션 청산 포지션 증가함 감소 순주식 변동
128 (-51 이전 분기 대비) 174 (+70 이전 분기 대비) 450 (-30 이전 분기 대비) 555 (-4 이전 분기 대비) +16.3M

Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.

기관 가치 주식 % 추적된 13F 중 유형
VANGUARD GROUP INC $6,118,113,464 13,104,814 15.52% 주식
VANGUARD CAPITAL MANAGEMENT LLC $3,954,150,533 10,141,708 10.03% 주식
Sanders Capital, LLC $3,442,060,818 8,828,287 8.73% 주식
STATE STREET CORP $2,912,102,056 7,469,035 7.39% 주식
WELLINGTON MANAGEMENT GROUP LLP $1,750,298,867 4,489,212 4.44% 주식
GEODE CAPITAL MANAGEMENT, LLC $1,225,259,672 3,159,159 3.11% 주식
VANGUARD PORTFOLIO MANAGEMENT LLC $1,057,704,509 2,712,828 2.68% 주식
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $861,456,107 2,209,485 2.18% 주식
NORGES BANK $836,457,140 2,145,367 2.12% 주식
Capital World Investors $770,864,224 1,977,121 1.96% 주식
Capital International Investors $747,403,041 1,916,947 1.90% 주식
Crake Asset Management LLP $449,072,183 1,151,792 1.14% 주식
Metropolis Capital Ltd $430,915,307 910,564 1.09% 주식
Darsana Capital Partners LP $428,879,000 1,100,000 1.09% 주식
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $414,533,777 1,063,207 1.05% 주식
Life Cycle Investment Partners Ltd $355,737,196 912,404 0.90% 주식
VANGUARD FIDUCIARY TRUST CO $339,685,814 871,235 0.86% 주식
FMR LLC $325,199,295 834,080 0.82% 주식
BARCLAYS PLC $299,888,573 769,162 0.76% 주식
LYRICAL ASSET MANAGEMENT LP $255,015,742 654,071 0.65% 주식
BlackRock, Inc. $240,062,291 615,718 0.61% 주식
ROYAL LONDON ASSET MANAGEMENT LTD $235,649,908 604,401 0.60% 주식
National Pension Service $230,650,346 591,578 0.59% 주식
NORDEA INVESTMENT MANAGEMENT AB $230,189,125 594,466 0.58% 주식
GOLDMAN SACHS GROUP INC $209,775,669 538,038 0.53% 주식
Gobi Capital LLC $195,742,325 502,045 0.50% 주식
Cryder Capital Partners LLP $194,561,738 499,017 0.49% 주식
Swiss National Bank $172,097,446 441,400 0.44% 주식
AustralianSuper Pty Ltd $159,635,782 409,438 0.40% 주식
Consulta Ltd $155,956,000 400,000 0.40% 주식
LEE DANNER & BASS INC $152,150,679 390,240 0.39% 주식
SUSQUEHANNA INTERNATIONAL GROUP, LLP $151,472,265 388,500 0.38% 콜 옵션
Mitsubishi UFJ Asset Management Co., Ltd. $147,943,761 379,450 0.38% 주식
DIMENSIONAL FUND ADVISORS LP $139,697,405 358,300 0.35% 주식
Vanguard Global Advisers, LLC $136,962,509 351,285 0.35% 주식
VIRGINIA RETIREMENT SYSTEMS ET Al $134,838,505 288,820 0.34% 주식
ALLIANCEBERNSTEIN L.P. $134,459,788 284,126 0.34% 주식
Sumitomo Mitsui Trust Group, Inc. $132,794,974 340,596 0.34% 주식
TD Asset Management Inc $131,847,152 338,165 0.33% 주식
Legal & General Group Plc $127,805,162 327,798 0.32% 주식
California Public Employees Retirement System $124,133,958 318,382 0.31% 주식
LAZARD ASSET MANAGEMENT LLC $120,619,879 309,369 0.31% 주식
JANE STREET GROUP, LLC $119,540,274 306,600 0.30% 콜 옵션
VANGUARD ASSET MANAGEMENT, Ltd $116,069,863 297,699 0.29% 주식
CAPTRUST FINANCIAL ADVISORS $114,741,071 294,291 0.29% 주식
ANTIPODES PARTNERS Ltd $113,045,096 289,941 0.29% 주식
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM $109,718,328 231,845 0.28% 주식
CITADEL ADVISORS LLC $105,660,190 271,000 0.27% 콜 옵션
RHUMBLINE ADVISERS $97,580,413 250,277 0.25% 주식
O'SHAUGHNESSY ASSET MANAGEMENT, LLC $97,026,076 248,855 0.25% 주식
MACKENZIE FINANCIAL CORP $93,597,383 240,061 0.24% 주식
BloombergSen Inc. $93,160,317 238,940 0.24% 주식
SUSQUEHANNA INTERNATIONAL GROUP, LLP $92,247,974 236,600 0.23% 풋 옵션
Brandywine Global Investment Management, LLC $89,380,814 191,451 0.23% 주식
BANK OF AMERICA CORP /DE/ $89,069,981 228,449 0.23% 주식
NEUBERGER BERMAN GROUP LLC $85,926,216 220,386 0.22% 주식
MILFORD FUNDS LTD $82,165,029 210,739 0.21% 주식
Bridgewater Associates, LP $79,227,208 203,204 0.20% 주식
Prana Capital Management, LP $75,552,494 193,779 0.19% 주식
DANSKE BANK A/S $73,238,497 187,844 0.19% 주식
FRANKLIN RESOURCES INC $70,965,828 182,015 0.18% 주식
VOLORIDGE INVESTMENT MANAGEMENT, LLC $70,445,715 180,681 0.18% 주식
Quantinno Capital Management LP $70,407,055 180,581 0.18% 주식
ARGENT CAPITAL MANAGEMENT LLC $69,149,681 177,357 0.18% 주식
Retirement Systems of Alabama $68,081,812 174,618 0.17% 주식
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND $66,167,842 169,709 0.17% 주식
BNP PARIBAS FINANCIAL MARKETS $64,793,090 166,183 0.16% 주식
BNP PARIBAS ASSET MANAGEMENT Holding S.A. $64,665,206 165,855 0.16% 주식
HSBC HOLDINGS PLC $64,431,534 165,332 0.16% 주식
AVIVA PLC $64,264,789 164,828 0.16% 주식
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC $64,194,533 135,649 0.16% 주식
SEB Asset Management AB $63,257,255 162,244 0.16% 주식
TODD ASSET MANAGEMENT LLC $62,567,208 160,474 0.16% 주식
Swedbank AB $62,528,998 160,376 0.16% 주식
W1M Investment Management Ltd $61,247,490 143,647 0.16% 주식
HARRIS ASSOCIATES L P $60,080,879 154,097 0.15% 주식
Ensign Peak Advisors, Inc $58,372,381 149,715 0.15% 주식
NEW YORK STATE COMMON RETIREMENT FUND $57,747,778 148,113 0.15% 주식
CITADEL ADVISORS LLC $57,235,852 146,800 0.15% 풋 옵션
Universal- Beteiligungs- und Servicegesellschaft mbH $57,160,993 146,800 0.14% 주식
LOS ANGELES CAPITAL MANAGEMENT LLC $56,512,217 144,944 0.14% 주식
Pictet Asset Management Holding SA $52,147,803 133,739 0.13% 주식
VICTORY CAPITAL MANAGEMENT INC $50,752,761 130,172 0.13% 주식
Pentwater Capital Management LP $50,685,700 130,000 0.13% 주식
D. E. Shaw & Co., Inc. $50,554,307 129,663 0.13% 주식
APG Asset Management N.V. $50,368,550 147,699 0.13% 주식
AMF Tjanstepension AB $50,355,853 129,154 0.13% 주식
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM $50,349,225 129,137 0.13% 주식
EQUITABLE TRUST CO $49,147,974 126,056 0.12% 주식
ENVESTNET ASSET MANAGEMENT INC $48,919,124 125,469 0.12% 주식
CANADA PENSION PLAN INVESTMENT BOARD $48,197,812 123,619 0.12% 주식
AMERICAN CENTURY COMPANIES INC $47,460,140 121,727 0.12% 주식
OpenArc Corporate Advisory, LLC $47,210,610 121,087 0.12% 주식
L1 Capital International Pty Ltd $46,121,648 118,294 0.12% 주식
FIRST TRUST ADVISORS LP $44,251,579 113,498 0.11% 주식
PFA Pension, Forsikringsaktieselskab $44,046,098 112,971 0.11% 주식
United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund $43,830,264 112,417 0.11% 주식
EP Wealth Advisors, LLC $43,287,826 111,026 0.11% 주식
WOLVERINE TRADING, LLC $42,597,104 101,200 0.11% 콜 옵션
MERCER GLOBAL ADVISORS INC /ADV $42,302,070 108,497 0.11% 주식

회사 내부자 91 명의 내부자 · 54 임원 · 31 이사

내부자 역할 마지막 활동 보유 주식 수 매수 12개월 매도 12개월 순매수/매도 12개월
Samuel N Hazen CEO 2026년 2월 10일 F 64,842 0 7 $-21,483,290
O'Boyle Michael P President & CEO - Parallon 2013년 2월 26일 A 21,429 0 0 $0
Mike A Marks EVP and CFO 2026년 5월 7일 G 46,576 0 0 $0
Bill B Rutherford CFO and EVP 2024년 2월 16일 F 22,251 0 0 $0
Russell K Harms CFO - Central Group 2006년 11월 17일 D 0 0 0 $0
Robert Samuel Hankins JR CFO-Outpatient Services Group 2006년 11월 17일 D 0 0 0 $0
Richard J Shallcross CFO - Western Group 2006년 11월 17일 D 0 0 0 $0
Jeffrey T Crudele CFO-Eastern Division 2005년 7월 1일 F 13,865 0 0 $0
Erol R Akdamar Group President 2024년 11월 12일 M 6,843 0 0 $0
Timothy M Mcmanus Group President 2024년 7월 31일 M 27,008 0 0 $0
Richard A Hammett Group President 2024년 2월 16일 F 17,936 0 0 $0
Charles J Hall Group President 2022년 11월 11일 M 202,443 0 0 $0
Bruce A Moore JR Group President - Service Line 2022년 11월 11일 S 30,807 0 0 $0
Paul W Rutledge Group President 2012년 12월 31일 A 335,657 0 0 $0
Beverly B Wallace President - Parallon 2011년 11월 2일 M 144,714 0 0 $0
Charles Robert Evans President - Eastern Group 2006년 7월 26일 A 62,173 0 0 $0
Marilyn B Tavenner President-Outpatient Svcs Grp 2005년 10월 27일 A 26,154 0 0 $0
Greg Roth President-Ambulatory Surgery 2004년 10월 31일 D 9,029 0 0 $0
Jay Grinney President-Eastern Group 2004년 5월 7일 D 24,177 0 0 $0
Jon M Foster EVP and COO 2026년 2월 10일 F 23,062 0 0 $0
Michael R Mcalevey EVP & Chief Legal & Admin Off. 2026년 2월 13일 M 8,853 0 2 $-2,747,520
Jennifer Berres SVP & Chief Human Res. Officer 2026년 2월 11일 S 11,993 0 2 $-4,126,932
Christopher F. Wyatt SVP & Controller 2026년 2월 11일 S 44,379 0 1 $-2,020,000
Erica Rossitto SVP & Chief Nurse Executive 2026년 2월 10일 F 10,407 0 0 $0
Michael S. Cuffe EVP and Chief Clinical Officer 2026년 2월 10일 F 32,080 0 1 $-747,135
Sammie S Mosier SVP & Chief Nurse Executive 2025년 2월 13일 F 11,113 0 0 $0
Kathleen M Whalen SVP & Chief Ethics Officer 2024년 11월 14일 S 9,454 0 0 $0
Phillip G Billington SVP-Internal Audit Services 2024년 11월 12일 M 52,702 0 0 $0
Joseph A Sowell III SVP; Chief Development Officer 2024년 8월 5일 G 18,526 0 0 $0
Deborah M Reiner SVP - Mktg. & Communications 2024년 7월 29일 S 3,510 0 0 $0
Kathryn A. Torres SVP-Payer Contracting & Align. 2024년 7월 25일 S 17,755 0 0 $0
Jeffrey E. Cohen SVP-Government Relations 2024년 5월 9일 S 5,185 0 0 $0
Chad J Wasserman SVP and CIO 2024년 3월 18일 M 1,576 0 0 $0
Martin P. Paslick SVP and CIO 2023년 4월 12일 M 24,643 0 0 $0
Jane D. Englebright SVP and Chief Nursing Officer 2021년 11월 9일 S 0 0 0 $0
Robert A Waterman SVP & General Counsel 2021년 5월 5일 S 50,062 0 0 $0
William J Morrow SVP - Finance and Treasurer 2021년 2월 18일 F 5,578 0 0 $0
Sandra L. Morgan SVP-Provider Relations 2021년 2월 18일 F 10,122 0 0 $0
Victor L Campbell SVP-Government Affairs 2019년 5월 1일 A 194,145 0 0 $0
John M Steele SVP & Chief Human Res. Officer 2019년 2월 25일 M 84,157 0 0 $0
Milton R Johnson Chairman 2019년 2월 25일 M 881,823 0 0 $0
Ravi S. Chari SVP-Clinical Excellence 2018년 2월 25일 M 7,003 0 0 $0
Alan R Yuspeh SVP & Chief Ethics Officer 2018년 2월 25일 M 35,546 0 0 $0
Joseph N Steakley SVP-Internal Audit Services 2018년 2월 25일 M 65,199 0 0 $0
Jana Joustra Davis SVP - Mktg. & Corp. Affairs 2017년 5월 23일 M 26,378 0 0 $0
David Gwin Anderson SVP - Finance 2016년 11월 7일 M 110,167 0 0 $0
Donald W Stinnett SVP & Controller 2016년 2월 25일 A 51,965 0 0 $0
Noel B Williams SVP and CIO 2012년 5월 16일 M 299,030 0 0 $0
Jack O Bovender JR Chairman 2009년 10월 6일 A 188,340 0 0 $0
Carl V George SVP - Development 2009년 2월 27일 M 13,092 0 0 $0

SEC 양식 3/4/5 제출 서류 기준 내부자; 순매수/매도는 공개 시장 거래만 해당

행동주의자 및 5% 이상 소유자 4 보유

SEC 서류 13D를 제출한 투자자 — 발행인에 영향을 미치려는 의도로 5% 이상의 실질 소유권(행동주의 지분, 이사회 캠페인, M&A). 각 행은 해당 제출자의 포지션에 대한 가장 최근에 알려진 상태를 보여줍니다.

제출자 제출됨 지분 상태 목적 제출
Frisco Holding II, Hercules Holding II, Thomas F. Frist, Jr., Thomas F. Frist III, William R. Frist, Patricia F. Elcan 2026년 2월 10일 31.60% 최초 제출 SEC
2006년 11월 22일 최초 제출 SEC
Merrill Lynch Bank USA 2006년 9월 11일 최초 제출 SEC
Frisco, Inc., Frisco Partners, Thomas F. Frist, Jr., Patricia Champion Frist, Patricia Frist Elcan, William Robert Frist, Thomas F. Frist III, Merrill Lynch Professional Clearing Corp., Merrill Lynch, Pierce, Fenner & Smith Incorporated, Merrill Lynch Financial Markets, Inc., Merrill Lynch International, Merrill Lynch & Co., Inc., Merrill Lynch Trust Company, FSB, Citigroup Inc.*, Bank of America Corporation, NB Holdings Corporation, NationsBanc Montgomery Holdings Corporation, Banc of America Securities LLC 2006년 8월 4일 최초 제출 SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF 보유 현황 207 ETF 보유

가중치는 직접적인 주식 보유(N-PORT)만 반영합니다. 레버리지 또는 파생 상품 기반 펀드는 표시되지 않은 추가 스왑 노출을 보유할 수 있습니다.

펀드 비중 단위 기준일 출처
IHF · iShares Trust 4.67% 141,320 SH 2026년 8월 8일 일간
BUL · Pacer Funds Trust 3.91% 11,437 NS 2026년 4월 30일 N-PORT
YALL · Tidal Trust I 3.61% 9,261 NS 2026년 5월 31일 N-PORT
BWTG · ETF Opportunities Trust 3.02% 1,646 NS 2026년 5월 31일 N-PORT
PKW · Invesco Exchange-Traded Fund Trust 2.32% 99,335 SH 2026년 8월 8일 일간
ABIG · EA Series Trust 2.00% 2,938 NS 2026년 5월 29일 N-PORT
FXH · First Trust Exchange-Traded AlphaDE… 1.99% 39,985 NS 2026년 4월 30일 N-PORT
RSPH · Invesco Exchange-Traded Fund Trust 1.67% 31,685 SH 2026년 8월 8일 일간
COWZ · Pacer Funds Trust 1.64% 688,264 NS 2026년 4월 30일 N-PORT
QQWZ · Pacer Funds Trust 1.64% 1,762 NS 2026년 4월 30일 N-PORT
FEGE · RBB Fund Trust 1.46% 74,706 NS 2026년 5월 31일 N-PORT
PWV · Invesco Exchange-Traded Fund Trust 1.39% 60,385 SH 2026년 8월 8일 일간
RPG · Invesco Exchange-Traded Fund Trust 1.30% 63,448 SH 2026년 8월 8일 일간
TMFE · RBB Fund, Inc. 1.29% 2,892 NS 2026년 5월 31일 N-PORT
AMID · EA Series Trust 1.23% 3,402 NS 2026년 5월 29일 N-PORT
FCPI · FIDELITY COVINGTON TRUST 1.15% 7,180 NS 2026년 4월 30일 N-PORT
FMAG · FIDELITY COVINGTON TRUST 1.12% 6,544 NS 2026년 4월 30일 N-PORT
FHLC · FIDELITY COVINGTON TRUST 1.12% 73,639 NS 2026년 4월 30일 N-PORT
SRHQ · Elevation Series Trust 1.10% 4,883 NS 2026년 4월 30일 N-PORT
IYH · iShares Trust 0.99% 89,420 SH 2026년 8월 8일 일간
NEAR · iShares U.S. ETF Trust 0.99% 48,109,000 SH 2026년 8월 8일 일간
CURE · Direxion Shares ETF Trust 0.98% 3,122 NS 2026년 4월 30일 N-PORT
VHT · VANGUARD WORLD FUND 0.90% 470,451 SH 2026년 8월 8일 일간
NFRA · FlexShares Trust 0.88% 62,176 NS 2026년 4월 30일 N-PORT
REVS · Columbia ETF Trust I 0.87% 5,693 NS 2026년 4월 30일 N-PORT
RXL · ProShares Trust 0.86% 1,632 NS 2026년 5월 31일 N-PORT
DIVB · iShares Trust 0.85% 36,806 SH 2026년 8월 8일 일간
BSCT · Invesco Exchange-Traded Self-Indexe… 0.82% 24,078,000 2026년 8월 8일 일간
LSEQ · Harbor ETF Trust 0.81% 285 NS 2026년 4월 30일 N-PORT
IXJ · iShares Trust 0.80% 81,465 SH 2026년 8월 8일 일간
BSCS · Invesco Exchange-Traded Self-Indexe… 0.76% 26,493,000 2026년 8월 8일 일간
SPVM · Invesco Exchange-Traded Fund Trust 0.74% 2,335 SH 2026년 8월 8일 일간
FTC · First Trust Exchange-Traded AlphaDE… 0.73% 21,329 NS 2026년 4월 30일 N-PORT
RFFC · ALPS ETF Trust 0.68% 533 NS 2026년 5월 31일 N-PORT
QUVU · Hartford Funds Exchange-Traded Trust 0.68% 2,698 NS 2026년 4월 30일 N-PORT
VFMF · VANGUARD WELLINGTON FUND 0.67% 12,075 SH 2026년 8월 8일 일간
VCEB · VANGUARD WORLD FUND 0.62% 8,146,000 PA 2026년 8월 8일 일간
FDMO · FIDELITY COVINGTON TRUST 0.61% 11,771 NS 2026년 4월 30일 N-PORT
RECS · Columbia ETF Trust I 0.58% 72,768 NS 2026년 4월 30일 N-PORT
AFLG · First Trust Exchange-Traded Fund VI… 0.56% 9,664 NS 2026년 5월 31일 N-PORT
VFVA · VANGUARD WELLINGTON FUND 0.55% 11,876 SH 2026년 8월 8일 일간
VLLU · Harbor ETF Trust 0.54% 54 NS 2026년 4월 30일 N-PORT
LSVD · ADVISORS' INNER CIRCLE FUND 0.53% 7,404 NS 2026년 4월 30일 N-PORT
WLDR · Two Roads Shared Trust 0.51% 844 NS 2026년 4월 30일 N-PORT
VALQ · AMERICAN CENTURY ETF TRUST 0.50% 4,620 NS 2026년 5월 31일 N-PORT
AKAF · ETF Series Solutions 0.50% 39 NS 2026년 5월 31일 N-PORT
BSCR · Invesco Exchange-Traded Self-Indexe… 0.50% 22,679,000 2026년 8월 8일 일간
ROUS · Lattice Strategies Trust 0.47% 6,388 NS 2026년 4월 30일 N-PORT
VCLT · VANGUARD SCOTTSDALE FUNDS 0.46% 54,218,000 PA 2026년 8월 8일 일간
CGGR · Capital Group Growth ETF 0.45% 290,273 NS 2026년 5월 31일 N-PORT